FrancophonIA/ELRC3.0 huggingface dataset:
English: Very common side effects (may affect more than 1 in 10 people): Increased blood sugar, diabetes mellitus, increased potassium in the blood Difficulty in sleeping
Danish: Meget almindelige bivirkninger (kan forekomme hos flere end 1 ud af 10 behandlede): - Forhøjet blodsukker, sukkersyge, øget kaliumindhold i blodet - Søvnløshed - Rysten, hovedpine
English: As tacrolimus is a substance with low clearance, adjustments to the Advagraf dose regimen may take several days before steady state is achieved.
Danish: Da tacrolimus er et stof med lav clearance, kan det tage flere dage, inden steady state opnås efter justering af dosis.
English: In rats and rabbits, tacrolimus caused embryofoetal toxicity at doses which demonstrated maternal toxicity (see section 5.3).
Danish: Tacrolimus udviser embryo/føtal toksicitet hos rotter og kaniner ved doser, som var toksiske for moderen (se pkt.
English: to plasma proteins, mainly to serum albumin and α-1-acid glycoprotein.
Danish: I plasma er tacrolimus stærkt bundet (>98,8 %) til plasmaproteiner, hovedsagelig til serumalbumin og surt alfa-1-glykoprotein.
English: The printing ink used to mark Advagraf capsules contains soya lecithin.
Danish: Printblækket, som bruges til at stemple Advagrafkapslen med, indeholder sojalecithin.
English: : +370 37 408 681 Faks.
Danish: Biocodex UAB Tel.: +370 37 408 681 Faks.
English: Capsule shell: Titanium dioxide (E171), yellow iron oxide (E 172), red iron oxide (E 172), sodium laurilsulfate, gelatin.
Danish: Kapselskal: Titandioxid (E171), gul jernoxid (E172), rød jernoxid (E172), natriumlaurilsulfat, gelatine.
English: The 12-month patient survival rates were 96.9% for Advagraf and 97.5% for Prograf; in the Advagraf arm 10 patients died (3 female, 7 male) and in the Prograf arm 8 patients died (3 female, 5 male).
Danish: Overlevelsesraten efter 12 måneder var 96,9 % for Advagraf og 97,5 % for Prograf; i Advagrafgruppen døde 10 patienter (3 kvinder, 7 mænd), og i Prografgruppen døde 8 patienter (3 kvinder, 5 mænd).
English: encephalopathy, central nervous system haemorrhages and cerebrovascular accidents, coma, speech and language abnormalities, paralysis and paresis, amnesia rare:
Danish: encefalopati, blødning i centralnervesystemet og hjerneblødning, koma, taleog sprogforstyrrelser, paralyse og pareser, amnesi
English: Care should be taken when converting patients from ciclosporin-based to tacrolimus-based therapy (see sections 4.4 and 4.5).
Danish: Man bør udvise forsigtighed, når patienter skifter fra behandling med ciclosporin til tacrolimusbaseret behandling (se pkt.
English: Tacrolimus is widely metabolised in the liver, primarily by the cytochrome P450-3A4.
Danish: Tacrolimus metaboliseres i udstrakt grad i leveren, primært af CYP3A4.
English: Titanium dioxide (E 171) Yellow iron oxide (E 172) Red iron oxide (E 172) Sodium laurilsulfate Gelatin.
Danish: Titandioxid (E 171) Gul jernoxid (E 172) Rød jernoxid (E 172) Natriumlaurilsulfat Gelatine.
English: Advagraf 0.5 mg prolonged-release hard capsules Advagraf 1 mg prolonged-release hard capsules Advagraf 3 mg prolonged-release hard capsules Advagraf 5 mg prolonged-release hard capsules
Danish: Advagraf 0,5 mg depotkapsler, hårde Advagraf 1 mg depotkapsler, hårde Advagraf 3 mg depotkapsler, hårde Advagraf 5 mg depotkapsler, hårde tacrolimus
English: Excipients with known effect: Each capsule contains 306.52 mg lactose.
Danish: Hjælpestoffer, som behandleren skal være opmærksom på: hver kapsel indeholder 306,52 mg lactose.
English: Cyst formation in your pancreas Problems with blood flow in the liver - Serious illness with blistering of skin, mouth, eyes and genitals; increased hairiness - Thirst, fall, feeling of tightness in your chest, decreased mobility, ulcer
Danish: - Akut åndenød - Cystedannelse på bugspytkirtlen - Problemer med blodcirkulation i leveren - Alvorlig sygdom med blærer i huden, munden, øjnene og kønsorganerne, øget behåring - Tørst, øget tendens til at falde, trykken for brystet, nedsat bevægelighed, sår
English: Branch Belgique/Belgien Tél/Tel: + 32 (0)2 5580710
Danish: Astellas Pharma B.V.Branch Belgique/Belgien Tél/Tel: + 32 (0)2 5580710
English: Tacrolimus was started as continuous intravenous infusion at a dose of 0.025 mg/kg/day and oral tacrolimus was administered at a dose of 0.15 mg/kg/day with subsequent dose adjustments to target trough levels of 10 to 20 ng/ml.
Danish: Tacrolimus blev startet som kontinuerlig intravenøs infusion med doser på 0,025 mg/kg/dag, oral tacrolimus blev administreret i doser på 0,15 mg/kg/dag med følgende dosisjustering for at nå dalkoncentrationer på 10-20 ng/ml.
English: Advagraf blood levels can be affected by other medicines you take, and blood levels of other medicines can be affected by taking Advagraf, which may require interruption, an increase or a decrease in Advagraf dose.
Danish: Indholdet af Advagraf i blodet kan påvirkes af anden medicin, og Advagraf kan påvirke indholdet af anden medicin i blodet.
English: Marketing Authorisation Holder: Astellas Pharma Europe B.V. Sylviusweg 62
Danish: Indehaver af markedsføringstilladelsen: Astellas Pharma Europe B.V.
English: Excipients with known effect: Each capsule contains 51.09 mg lactose.
Danish: Hjælpestoffer, som behandleren skal være opmærksom på: hver kapsel indeholder 51,09 mg lactose.
English: Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription and herbal preparations.
Danish: Fortæl det altid til lægen eller på apoteket, hvis De bruger anden medicin eller har gjort det for nylig.
English: Rare side effects (may affect up to 1 in 1,000 people): Small bleedings in your skin due to blood clots Increased muscle stiffness
Danish: Sjældne bivirkninger (kan forekomme hos op til 1 ud af 1000 behandlede): - Små blødninger i huden - Øget muskelstivhed - Blindhed, døvhed - Væskeansamling omkring hjertet
English: Tacrolimus was started as continuous intravenous infusion at a dose of 0.05 mg/kg/day and oral tacrolimus was administered at a dose of 0.1 to 0.3 mg/kg/day with subsequent dose adjustments to target trough levels of 12 to 15 ng/ml.
Danish: Tacrolimus startede som kontinuerlig intravenøs infusion med doser på 0,05 mg/kg/dag, hvorefter oral tacrolimus blev administreret i doser på 0,1 - 0,3 mg/kg/dag med følgende dosisjustering for at nå dalkoncentrationer på 12 - 15 ng/ml.
English: Excipients with known effect: Each capsule contains 102.17 mg lactose.
Danish: Hjælpestoffer, som behandleren skal være opmærksom på: hver kapsel indeholder 102,17 mg lactose.
English: dehydration, hypoglycaemia, hypoproteinaemia, hyperphosphataemia Psychiatric disorders very common:
Danish: dehydrering, hypoglykæmi, hypoproteinæmi, hyperfosfatæmi
English: Strong interactions have been observed with antifungal agents such as ketoconazole, fluconazole, itraconazole, voriconazole and isavuconazole, the macrolide antibiotic erythromycin, HIV protease inhibitors (e.g. ritonavir, nelfinavir, saquinavir), HCV protease inhibitors (e.g. telaprevir, boceprevir, and the combination of ombitasvir and paritaprevir with ritonavir, when used with and without dasabuvir), or the CMV antiviral letermovir, the pharmacokinetic enhancer cobicistat, and the tyrosine kinase inhibitors nilotinib and imatinib.
Danish: CYP3A4-hæmmere som potentielt kan øge tacrolimus' blodkoncentrationer Det er påvist, at de følgende midler øger tacrolimus' blodkoncentration: Der er set kraftige interaktioner med svampemidler som ketoconazol, fluconazol, itraconazol, voriconazol og isavuconazol, det macrolide antibiotikum erythromycin, HIV-protease-hæmmere (f.eks. ritonavir, nelfinavir, saquinavir), HCV-protease-hæmmere (f.eks. telaprevir, boceprevir og en kombination af ombitasvir og paritaprevir sammen med ritonavir, når det anvendes med og uden dasabuvir) eller det CMV antivirale letermovir, den farmakokinetiske forstærker cobicistat og tyrosinkinasehæmmerne nilotinib og imatinib.
English: Excipients with known effect: Each capsule contains 510.9 mg lactose.
Danish: Hjælpestoffer, som behandleren skal være opmærksom på: hver kapsel indeholder 510,9 mg lactose.
English: For prophylaxis of transplant rejection in adult heart allograft recipients clinical data are not yet available for Advagraf.
Danish: Der er endnu ingen kliniske data tilgængelige for Advagraf ved profylaktisk behandling mod transplantatafstødning hos hjertetransplanterede voksne.
English: Increased blood pressure
Danish: øget fedtvæv
English: Neoplasms benign, malignant and unspecified Patients receiving immunosuppressive therapy are at increased risk of developing malignancies.
Danish: Patienter i immunsuppressiv behandling har en øget risiko for at få maligne lidelser.
English: nervous system disorders seizures, disturbances in consciousness, peripheral neuropathies, dizziness, paraesthesias and dysaesthesias, writing impaired uncommon:
Danish: forstyrrelser i nervesystemet, krampeanfald, bevidsthedsforstyrrelser, perifer neuropati, svimmelhed, paræstesier og dysæstesier, nedsat skriveevne
English: Kidney problems
Danish: ledproblemer
English: However, owing to the nephrotoxic potential of tacrolimus careful monitoring of renal function is recommended (including serial serum creatinine concentrations, calculation of creatinine clearance and monitoring of urine output).
Danish: målinger af serum-kreatininkoncentrationer, beregning af kreatininclearance og kontrol af diurese).
English: To suppress graft rejection, immunosuppression must be maintained; consequently, no limit to the duration of oral therapy can be given.
Danish: For at undertrykke transplantatafstødning skal immunsuppression vedligeholdes.
English: gastrointestinal signs and symptoms, vomiting, gastrointestinal and abdominal pains, gastrointestinal inflammatory conditions, gastrointestinal haemorrhages, gastrointestinal ulceration and perforation, ascites, stomatitis and ulceration, constipation, dyspeptic signs and symptoms, flatulence, bloating and distension, loose stools uncommon:
Danish: symptomer fra mave-tarmkanalen, opkastning, abdominalsmerter, inflammatoriske lidelser i mave-tarmkanalen, blødning i mave-tarmkanalen, ulceration og perforation i mave-tarmkanalen, ascites, ulcerøs stomatitis, obstipation, dyspepsi, flatulens, oppustethed, tynd afføring
English: In particular, you should tell your doctor if you are taking or have recently taken medicines like: - antifungal medicines and antibiotics, particularly so-called macrolide antibiotics, used to treat infections e.g. ketoconazole, fluconazole, itraconazole, voriconazole, clotrimazole, and isavuconazole, erythromycin, clarithromycin, josamycin, and rifampicin - letermovir, used to prevent illness caused by CMV (human cytomegalovirus) - HIV protease inhibitors (e.g ritonavir, nelfinavir, saquinavir), the booster medicine cobicistat, and combination tablets, used to treat HIV infection - HCV protease inhibitors (e.g. telaprevir, boceprevir, and the combination ombitasvir/paritaprevir/ritonavir with or without dasabuvir), used to treat hepatitis C infection - nilotinib and imatinib (used to treat certain cancers) - mycophenolic acid, used to suppress the immune system to prevent transplant rejection
Danish: erythromycin, clarithromycin, josamycin og rifampicin - letermovir, bruges til at forebygge sygdomme forårsaget af CMV (human cytomegalovirus) - HIV-protease-hæmmere (f.eks. ritonavir, nelfinavir, saquinavir), boostermedicinen cobicitstat og kombinationstabletter, som bruges ved behandling af HIV-infektion - HCV-protease-hæmmere (f.eks. telaprevir, boceprevir og kombinationen ombitasvir/paritaprevir/ritonavir med eller uden dasabuvir), som bruges til behandling af hepatitis C-infektion - nilotinib og imatinib (bruges til behandling af visse typer cancer) - mycophenolsyre, som bruges til at undertrykke immunsystemet for at forhindre afstødning af et transplantat - medicin til forebyggelse og behandling af mavesår og spiserørskatar (f.eks. omeprazol,
English: Each capsule of Advagraf 0.5 mg contains 0.5 mg of tacrolimus (as monohydrate).
Danish: Hver kapsel Advagraf 0,5 mg indeholder 0,5 mg tacrolimus (som monohydrat).
English: - This medicine has been prescribed for you only.
Danish: - Lægen har ordineret Advagraf til Dem personligt.
English: - medicines for stomach ulcer and acid reflux (e.g. omeprazole, lansoprazole or cimetidine) - antiemetics, used to treat nausea and vomiting (e.g. metoclopramide) - cisapride or the antacid magnesium-aluminium-hydroxide, used to treat heartburn - the contraceptive pill or other hormone treatments with ethinylestradiol, hormone treatments with danazol - medicines used to treat high blood pressure or heart problems (e.g. nifedipine, nicardipine, diltiazem and verapamil) - anti-arrhythmic drugs (amiodarone) used to control arrhythmia (uneven beating of the heart) - medicines known as “statins” used to treat elevated cholesterol and triglycerides - phenytoin or phenobarbital, used to treat epilepsy - the corticosteroids prednisolone and methylprednisolone, belonging to the class of corticosteroids used to treat inflammations or suppress the immune system (e.g. in transplant rejection) - nefazodone, used to treat depression
Danish: lansoprazol eller cimetidin) - antiemetika, der anvendes til behandling af kvalme og opkastning (f.eks. metoclopramid) - cisaprid eller det syreneutraliserende middel magnesium-aluminium-hydroxid, der anvendes til behandling af halsbrand - p-piller eller anden hormonbehandling med ethinylestradiol, hormonbehandling med danazol - medicin mod forhøjet blodtryk eller hjerteproblemer (f.eks. nifedipin, nicardipin, diltiazem og verapamil)
English: Each capsule of Advagraf 1 mg contains 1 mg of tacrolimus (as monohydrate).
Danish: Hver kapsel Advagraf 1 mg indeholder 1 mg tacrolimus (som monohydrat).
English: 30 prolonged-release hard capsules 30×1 prolonged-release hard capsules 50 prolonged-release hard capsules 50×1 prolonged-release hard capsules 60 prolonged-release hard capsules 60×1 prolonged-release hard capsules 100 prolonged-release hard capsules 100×1 prolonged-release hard capsules
Danish: 30 depotkapsler, hårde 30×1 depotkapsler, hårde 50 depotkapsler, hårde 50×1 depotkapsler, hårde 60 depotkapsler, hårde 60×1 depotkapsler, hårde 100 depotkapsler, hårde 100×1 depotkapsler, hårde
English: Advagraf 0.5 mg prolonged-release hard capsules are hard gelatin capsules imprinted in red with “0.5 mg” on the light yellow capsule cap and “ 647” on the orange capsule body, containing white powder.
Danish: Advagraf 0,5 mg depotkapsler, hårde, med indhold af hvidt pulver er hårde gelatinekapsler præget med rødt ”0.5 mg” på den lysegule kapsel top og ”* 647” på den orange kapselbund.
English: Advagraf therapy should be initiated after considering ciclosporin blood concentrations and the clinical condition of the patient.
Danish: Blodkoncentrationerne af ciclosporin og patientens tilstand skal tages i betragtning, før man indleder behandling med Advagraf.
English: Each capsule of Advagraf 3 mg contains 3 mg of tacrolimus (as monohydrate).
Danish: Hver kapsel Advagraf 3 mg indeholder 3 mg tacrolimus (som monohydrat).
English: Each capsule of Advagraf 5 mg contains 5 mg of tacrolimus (as monohydrate).
Danish: Hver kapsel Advagraf 5 mg indeholder 5 mg tacrolimus (som monohydrat).
English: Astellas Pharma S.p.A. Tel: + 39 (0)2 921381
Danish: Tel: + 39 (0)2 921381
English: Common side effects (may affect up to 1 in 10 people): - Reduction in blood cell counts (platelets, red or white blood cells), increase in white blood cell counts, changes in red blood cell counts (seen in blood tests) Reduced magnesium, phosphate, potassium, calcium or sodium in the blood, fluid overload, increased uric acid or lipids in the blood, decreased appetite, increased acidity of the blood, other changes in the blood salts (seen in blood tests) - Anxiety symptoms, confusion and disorientation, depression, mood changes, nightmare, hallucination, mental disorders - Fits, disturbances in consciousness, tingling and numbness (sometimes painful) in the hands and feet, dizziness, impaired writing ability, nervous system disorders - Blurred vision, increased sensitivity to light, eye disorders Ringing sound in your ears
Danish: Ikke almindelige bivirkninger (kan forekomme hos op til 1 ud af 100 behandlede): - Ændret blodstørkning, nedsat antal af alle typer af blodceller (ses i blodprøver) - Dehydrering, ophørt urinproduktion - Unormale resultater af blodprøver: Nedsat protein og sukker, øget fosfat, stigning i enzymet laktatdehydrogenase - Koma, blødning i hjernen, slagtilfælde, lammelse, forandringer i hjernen, tale- og sprogforstyrrelser, hukommelsesproblemer - Uklarhed af øjenlinsen, nedsat hørelse - Uregelmæssigt hjerteslag, hjertestop, hjertesvigt, forstyrrelser i hjertemuskulaturen, forstørret hjertemuskulatur, øget puls, unormalt EKG, unormalt hjerteslag og puls - Blodprop i vene i lemmerne, shock - Åndedrætsbesvær, lidelser i luftvejene, astma - Tarmslyng, øget blodniveau af enzymet amylase, tilbageløb af maveindhold, forsinket tømning af mavesækken - Betændelsestilstand i huden, brændende fornemmelse i sollys - Ledproblemer - Smertefuld menstruation og unormal menstruationsblødning - Multiorgansvigt, influenzalignende sygdom, øget temperaturfølsomhed, trykken for brystet,
English: Advagraf 3 mg prolonged-release hard capsules EU/1/07/387/011
Danish: Advagraf 3 mg depotkapsler, hårde EU/1/07/387/011
English: Advagraf 1 mg prolonged-release hard capsules Tacrolimus
Danish: Advagraf 1 mg depotkapsler, hårde Tacrolimus
English: Advagraf 5 mg prolonged-release hard capsules are hard gelatin capsules imprinted in red with “5 mg” on the greyish red capsule cap and “ 687” on the orange capsule body, containing white powder.
Danish: Advagraf 5 mg depotkapsler, hårde, med indhold af hvidt pulver er hårde gelatinekapsler præget med rødt ”5 mg” på den grå-røde kapseltop og ”* 687” på den orange kapselbund.
English: The treatment difference (Advagraf - Prograf) was 3.3% (95% confidence interval [5.7%, 12.3%]).The 12-month patient survival rates were 89.2% for Advagraf and 90.8% for Prograf; in the Advagraf arm 25 patients died (14 female, 11 male) and in the Prograf arm 24 patients died (5 female, 19 male).
Danish: Overlevelsesraten efter 12 måneder var 89,2 % for Advagraf og 90,8 % for Prograf; i Advagrafgruppen døde 25 patienter (14 kvinder, 11 mænd), og i Prografgruppen døde 24 patienter (5 kvinder, 19 mænd).
English: Advagraf 0.5 mg prolonged-release hard capsules Each prolonged-release hard capsule contains 0.5 mg tacrolimus (as monohydrate).
Danish: Advagraf 0,5 mg depotkapsler, hårde Hver depotkapsel, hård, indeholder 0,5 mg tacrolimus (som monohydrat).
English: 30 prolonged-release hard capsules 30×1 prolonged-release hard capsules 50 prolonged-release hard capsules 50×1 prolonged-release hard capsules 100 prolonged-release hard capsules 100×1 prolonged-release hard capsules
Danish: 30 depotkapsler, hårde 30×1 depotkapsler, hårde 50 depotkapsler, hårde 50×1 depotkapsler, hårde 100 depotkapsler, hårde 100×1 depotkapsler, hårde
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON Advagraf 0.5 mg prolonged-release hard capsules
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE KARTON Advagraf 0,5 mg depotkapsler, hårde
English: Advagraf 1 mg prolonged-release hard capsules are hard gelatin capsules imprinted in red with “1 mg” on the white capsule cap and “ 677” on the orange capsule body, containing white powder.
Danish: Advagraf 1 mg depotkapsler, hårde, med indhold af hvidt pulver er hårde gelatinekapsler præget med rødt ”1 mg” på den hvide kapseltop og ”* 677” på den orange kapselbund.
English: Advagraf 3 mg prolonged-release hard capsules are hard gelatin capsules imprinted in red with “3 mg” on the orange capsule cap and “ 637” on the orange capsule body, containing white powder.
Danish: Advagraf 3 mg depotkapsler, hårde, med indhold af hvidt pulver er hårde gelatinekapsler præget med rødt ”3 mg” på den orange kapseltop og ”* 637” på den orange kapselbund.
English: Each capsule contains 0.5 mg tacrolimus (as monohydrate).
Danish: Hver kapsel indeholder 0,5 mg tacrolimus (som monohydrat).
English: Tacrolimus was started as continuous intravenous infusion at a dose of 0.01 to 0.03 mg/kg/day and oral tacrolimus was administered at a dose of 0.05 to 0.3 mg/kg/day.
Danish: Tacrolimus blev startet som kontinuerlig intravenøs infusion i doser på 0,01 mg - 0,03 mg/kg/dag.
English: Advagraf 1 mg prolonged-release hard capsules Each prolonged-release hard capsule contains 1 mg tacrolimus (as monohydrate).
Danish: Advagraf 1 mg depotkapsler, hårde Hver depotkapsel, hård, indeholder 1 mg tacrolimus (som monohydrat).
English: Dosing should be delayed in the presence of elevated ciclosporin blood levels.
Danish: I tilfælde af forhøjede ciclosporin-blodkoncentrationer bør doseringen udsættes.
English: Advagraf 3 mg prolonged-release hard capsules Each prolonged-release hard capsule contains 3 mg tacrolimus (as monohydrate).
Danish: Advagraf 3 mg depotkapsler, hårde Hver depotkapsel, hård, indeholder 3 mg tacrolimus (som monohydrat).
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON Advagraf 1 mg prolonged-release hard capsules
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE KARTON Advagraf 1 mg depotkapsler, hårde
English: Gelatin capsules imprinted in red with “3 mg” on the orange capsule cap and “ 637” on the orange capsule body, containing white powder.
Danish: Gelatinekapsler, indeholdende hvidt pulver, præget med ”3 mg” i rødt på den orange kapseltop og med ” 637” på den orange kapselbund.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER Advagraf 0.5 mg prolonged-release hard capsules
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP BLISTER Advagraf 0,5 mg depotkapsler, hårde
English: Advagraf 0.5 mg prolonged-release hard capsules Tacrolimus
Danish: Advagraf 0,5 mg depotkapsler, hårde Tacrolimus
English: Gelatin capsules imprinted in red with “1 mg” on the white capsule cap and “ 677” on the orange capsule body, containing white powder.
Danish: Gelatinekapsler, indeholdende hvidt pulver, præget med ”1 mg” i rødt på den hvide kapseltop og med ” 677” på den orange kapselbund.
English: Advagraf 3 mg prolonged-release hard capsules Tacrolimus
Danish: Advagraf 3 mg depotkapsler, hårde Tacrolimus
English: MINIMUM PARTICULARS TO APPEAR ON BLISTER WRAPPERS ALUMINIUM WRAPPER Advagraf 1 mg prolonged-release hard capsules (30, 50, 60, 100 Aluminium Wrapper)
Danish: MINDSTEKRAV TIL MÆRKNING PÅ SMÅ INDRE EMBALLAGER ALUMINIUMPOSER Advagraf 1 mg depotkapsler, hårde (30, 50, 60, 100 ALUMINIUMPOSER)
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER Advagraf 1 mg prolonged-release hard capsules
Danish: MINDSTEKRAV TIL MÆRKNING PÅ BLISTER ELLER STRIP BLISTER Advagraf 1 mg depotkapsler, hårde
English: Pack sizes: 30, 50, 60 and 100 prolonged-release hard capsules in blisters or 30×1, 50×1, 60×1 and 100×1 prolonged-release hard capsule in unit-dose perforated blisters.
Danish: Pakningsstørrelser: 30, 50, 60 og 100 depotkapsler, hårde, i blister eller 30×1, 50×1, 60×1 og 100×1 depotkapsler, hårde, i perforeret enkeltdosisblister.
English: Advagraf 5 mg prolonged-release hard capsules Each prolonged-release hard capsule contains 5 mg tacrolimus (as monohydrate).
Danish: Advagraf 5 mg depotkapsler, hårde Hver depotkapsel, hård, indeholder 5 mg tacrolimus (som monohydrat).
English: Gelatin capsules imprinted in red with “0.5 mg” on the light yellow capsule cap and “ 647” on the orange capsule body, containing white powder.
Danish: Gelatinekapsler indeholdende hvidt pulver, præget med ”0.5 mg” i rødt på den lysegule kapseltop og med ” 647” på den orange kapselbund.